DBITE
US trademark, USPTO serial 97341385
"DBITE" is a pending US trademark filing (serial 97341385), owned by Amgen Research (Munich) GmbH, filed March 31, 2022.
Get an email when this status changes
We email you about office actions, publication and registration for free, and we check after each USPTO data update.
Informational only, not a legal opinion. Consult a trademark attorney before filing or enforcing.
Filing details
| Status | Pending |
| Serial number | 97341385 |
| Filing date | March 31, 2022 |
| Owner | Amgen Research (Munich) GmbH (2 filings) |
| NICE classes | Class 5, Class 9, Class 16, Class 35, Class 42 |
Goods and services
Medicaments, namely, polypeptides, for use in the treatment of tumorous diseases, cancer, allergies, autoimmunity, inflammation, osteoporosis, graft versus host diseases, transplant rejection, cardiovascular diseases, metabolic diseases, neurological diseases, and minimal residual diseases
Source and method
Built from public USPTO trademark records via WikiTrademarks. We match by exact wording, whole-word, phonetic sound-alike, and fuzzy look-alike, scoped by NICE class. Data reflects the most recent USPTO import. Last updated November 20, 2026.
Cite this page: WikiTrademarks, "DBITE trademark (serial 97341385)", https://wikitrademarks.com/trademark/97341385/dbite (accessed November 20, 2026).